Connect with us

Hi, what are you looking for?

Nasdaq:IMNN

#Imunon #Appoints #James #Dentzer #Board #Directors CEO of Curis brings extensive biopharmaceutical financial experience to the Board LAWRENCEVILLE, N.J., Oct. 03, 2022 (GLOBE NEWSWIRE)...

Nasdaq:IMNN

#Imunon #Reports #Inducement #Grants #NASDQ #Listing #Rule LAWRENCEVILLE, N.J., Sept. 29, 2022 (GLOBE NEWSWIRE) — Imunon, Inc. (NASDAQ: IMNN), a clinical-stage drug development company focused...